Loading organizations...
§ Venture Capital · Chengdu, China
Investment firm managing equity investment funds for biotech and tech startups, focused on early-stage seed VC.
Chengdu Biocity Fund is an investment firm channeling capital into the bio-industry, primarily within Chengdu, China. It manages various investment funds, strategically backing biotechnology ventures to foster growth and innovation in the life sciences sector. The firm's approach involves targeted financial support and expertise for the development of emerging bio-enterprises.
Established in 2019, Chengdu Biocity Equity Investment Fund Management emerged as part of Chengdu's strategy to cultivate a robust bio-industry ecosystem. Its formation is intrinsically linked to the Chengdu Hi-Tech Development Zone and the development of the Chengdu Tianfu International Bio-Town. This underscores a public-private impetus to accelerate regional life science capabilities.
The fund targets early-stage biotechnology and healthcare companies seeking investment and strategic support. Chengdu Biocity Fund aims to establish Chengdu as a leading center for life sciences innovation. Its vision involves nurturing a vibrant ecosystem of bio-enterprises, contributing significantly to advancements in healthcare and regional economic prosperity.
Chengdu Biocity Fund has 2 tracked investments across 2 companies. The latest tracked deal is $14.0M Series C in Qitan Technology in December 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 28, 2023 | Qitan Technology | $14.0M Series C | Chengdu Biocity Fund, Zhiyuan Capital | — |
| Dec 21, 2023 | Novamab | $14.0M Series B | — | — |